학술논문
The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience
Document Type
article
Author
Source
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Subject
Language
English
ISSN
2297-055X
Abstract
Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of non-statin lipid lowering therapies in accordance with the 2022 American College of Cardiology Expert Consensus Clinical Decision Pathway on the Role of Non-statin Therapies for LDL-Cholesterol Lowering. We also present a single-center experience implementing a systematic inpatient protocol for lipid lowering therapy for secondary prevention of ASCVD.